WallStSmart

Churchill Capital Corp XI (CCXI)vsVendome Acquisition Corporation I Class A Ordinary Shares (VNME)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

VNME leads profitability with a 0.0% profit margin vs 0.0%. VNME earns a higher WallStSmart Score of 23/100 (F).

CCXI

Avoid

23

out of 100

Grade: F

Growth: 4.3Profit: 3.5Value: 5.0Quality: 4.0
Piotroski: 2/9

VNME

Avoid

23

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 5.3

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

VNME0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$746.38M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

VNME4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$257.00M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : VNME

VNME has a balanced fundamental profile.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : VNME

The primary concerns for VNME are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

VNME is growing revenue faster at 0.0% — sustainability is the question.

VNME generates stronger free cash flow (-136,127), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCXI scores higher overall (23/100 vs 23/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

Vendome Acquisition Corporation I Class A Ordinary Shares

FINANCIAL SERVICES · SHELL COMPANIES · USA

Vendome Acquisition Corporation I (VNME) is an investment firm focused on identifying and merging with high-growth, innovative companies across diverse sectors. Leveraging a seasoned management team with deep industry expertise, VNME aims to enhance the growth trajectories of its portfolio companies through strategic capital deployment and guidance. By aligning its investment strategy with emerging market trends, VNME offers institutional investors a unique opportunity to engage with transformative businesses poised for significant returns.

Want to dig deeper into these stocks?